These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33825059)

  • 81. Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
    Alitti C; Rode A; Trillaud H; Merle P; Blanc JF; Blaise L; Demory A; Nkontchou G; Grando V; Ziol M; Nahon P; Ganne-Carrié N; Petit A; Seror O; Sutter O; Nault JC
    Liver Int; 2024 Jun; 44(6):1363-1372. PubMed ID: 38436538
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Long-term outcomes of combined radiofrequency ablation and multipronged ethanol ablation for the treatment of unfavorable hepatocellular carcinoma.
    Liu M; Li XJ; Zhang XE; Kuang M; Xie XY; Huang GL
    Diagn Interv Radiol; 2023 Mar; 29(2):342-349. PubMed ID: 36987999
    [TBL] [Abstract][Full Text] [Related]  

  • 83. No-Touch Multi-bipolar Radiofrequency Ablation for the Treatment of Subcapsular Hepatocellular Carcinoma ≤ 5 cm Not Puncturable via the Non-tumorous Liver Parenchyma.
    Petit A; Hocquelet A; N'kontchou G; Varin E; Sellier N; Seror O; Sutter O
    Cardiovasc Intervent Radiol; 2020 Feb; 43(2):273-283. PubMed ID: 31673728
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases.
    Wang CZ; Yan GX; Xin H; Liu ZY
    World J Gastrointest Oncol; 2020 Sep; 12(9):1044-1055. PubMed ID: 33005297
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
    Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J
    J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Short- and-long term results of intraoperative radiofrequency ablation of liver metastases.
    Navarra G; Ayav A; Weber JC; Jensen SL; Smadga C; Nicholls JP; Habib NA; Jiao LR
    Int J Colorectal Dis; 2005 Nov; 20(6):521-8. PubMed ID: 15864606
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm.
    Yan JY; Zhang JL; Wang MQ; Yuan K; Bai YH; Wang Y; Xin HN; Wang ZJ; Liu FY; Duan F; Fu JX
    Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Local recurrence rate in patients with colorectal cancer liver metastasis after wedge resection or percutaneous radiofrequency ablation.
    Vietti Violi N; Duran R; Demartines N; Sempoux C; Guiu B; Bize PE; Sala N; Halkic N; Knebel JF; Denys A
    Int J Hyperthermia; 2018 Nov; 34(7):1020-1028. PubMed ID: 29506424
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis.
    Abitabile P; Hartl U; Lange J; Maurer CA
    Eur J Surg Oncol; 2007 Feb; 33(1):67-71. PubMed ID: 17174059
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Treatment of hepatocellular carcinoma in the caudate lobe: US-guided percutaneous radiofrequency ablation combined with ethanol ablation.
    Liu B; Long J; Wang W; Huang G; Jiang C; Zhang X; Liu M; Liang P; Yu J; Xie X; Kuang M
    Clin Radiol; 2018 Jul; 73(7):647-656. PubMed ID: 29627066
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Predictors of Progression-Free Survival and Local Tumor Control after Percutaneous Thermal Ablation of Oligometastatic Breast Cancer: Retrospective Study.
    Ridouani F; Solomon SB; Bryce Y; Bromberg JF; Sofocleous CT; Deipolyi AR
    J Vasc Interv Radiol; 2020 Aug; 31(8):1201-1209. PubMed ID: 32698956
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A comparison of laparoscopic radiofrequency ablation versus systemic therapy alone in the treatment of breast cancer metastasis to the liver.
    Taşçi Y; Aksoy E; Taşkın HE; Aliyev S; Moore H; Ağcaoğlu O; Birsen O; Siperstein A; Berber E
    HPB (Oxford); 2013 Oct; 15(10):789-93. PubMed ID: 24028270
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation.
    Facciorusso A; Del Prete V; Muscatiello N; Crucinio N; Barone M
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1483-8. PubMed ID: 26896637
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Incidence and treatment of local site recurrences following RFA of colorectal liver metastases.
    Nielsen K; van Tilborg AA; Meijerink MR; Macintosh MO; Zonderhuis BM; de Lange ES; Comans EF; Meijer S; van den Tol MP
    World J Surg; 2013 Jun; 37(6):1340-7. PubMed ID: 23494086
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Stereotactic Radiofrequency Ablation of Hepatocellular Carcinoma: a Histopathological Study in Explanted Livers.
    Bale R; Schullian P; Eberle G; Putzer D; Zoller H; Schneeberger S; Manzl C; Moser P; Oberhuber G
    Hepatology; 2019 Sep; 70(3):840-850. PubMed ID: 30520063
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation.
    Zhang G; Liu P; Wang G; He X; Xu L; Wang Y; Li W; Peng W
    Discov Med; 2024 Apr; 36(183):765-777. PubMed ID: 38665025
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation.
    Ierardi AM; Floridi C; Fontana F; Chini C; Giorlando F; Piacentino F; Brunese L; Pinotti G; Bacuzzi A; Carrafiello G
    Radiol Med; 2013 Sep; 118(6):949-61. PubMed ID: 23892957
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Potential for cure and predictors of long-term survival after radiofrequency ablation for colorectal liver metastases: A 20-years single-center experience.
    Weilert H; Sadeghi D; Lipp M; Oldhafer KJ; Donati M; Stang A
    Eur J Surg Oncol; 2022 Dec; 48(12):2487-2494. PubMed ID: 35718675
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Propensity score matching demonstrates similar results for radiofrequency ablation compared to surgical resection in colorectal liver metastases.
    van de Geest TW; van Amerongen MJ; Nierop PMH; Höppener DJ; Grünhagen DJ; Moelker A; Fütterer JJ; Verhoef C; de Wilt JHW
    Eur J Surg Oncol; 2022 Jun; 48(6):1368-1374. PubMed ID: 35078702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.